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COPD- chronic obstructive pulmonary diseaseICS- inhaled corticosteroidcan be a particularly challenging time because there is a
reduction in parental supervision of asthma management as
the young person strives to become more autonomous. To
illustrate the importance of such factors, adherence in-
terventions in children and young adults with asthma have
used peer-based supports and social supports, particularly
social media platforms. In older patients, it is internal rather
than external factors and age-related decline that pose chal-
lenges to medication adherence. Seniors face the challenges of
polypharmacy, reduced social support, increased isolation,
and loss of cognitive function. Strategies to promote adher-
ence must be tailored to the developmental stage and
respective behavioral determinants of the target group. This
review considers the different attitudes toward medication
and the different adherence behaviors in young and elderly
patients with chronic respiratory conditions, speciﬁcally
asthma and chronic obstructive pulmonary disease. Oppor-
tunities to intervene to optimize adherence are sug-
gested.  2016 The Authors. Published by Elsevier Inc. on
behalf of the American Academy of Allergy, Asthma &
Immunology. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/). (J Allergy Clin Immunol Pract 2016;4:813-20)
Key words: Medication adherence; Implementation; Initiation;
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Cognitive impairment
The European Unionecommissioned “Ascertaining Barriers
to Compliance” taxonomy for medication adherence outlines 3
key steps in a “temporal sequence” that patients must take to be
adherent to their prescribed medication: initiation (picking up
and taking a ﬁrst medication), implementation (using it
correctly, as prescribed), and persistence (sustained use).1 As
individuals develop and mature, their social environment, care-
giver support, disease characteristics, and cognitive capabilities
change dramatically. These factors modify a patient’s ability to
manage medications and to adequately initiate, implement, and/
or persist with the prescribed regimen.
In childhood and old age, suboptimal adherence to asthma and/
or chronic obstructive pulmonary disease (COPD) treatment has
important and serious consequences. Asthma is the most common
chronic disease in children and a frequent cause of admission to
hospital.2 Poor adherence to controller therapy has a signiﬁcant
impact on children’s welfare, leading to increased school absence,
impaired social development, as well as the clinical adverse effects
of increased number of exacerbations.3-8 In the United Kingdom
in 2012-2013, 15% of all asthma deaths were in children and poor
adherence was evident in 48% of these cases.9
Asthma and COPD are both common conditions in the
elderly, yet few studies have speciﬁcally investigated the reasons
for suboptimal adherence to asthma and COPD treatments in
this age group. Early studies indicate that around two-third of
elderly patients with asthma or COPD have poor adherence with
their inhaled corticosteroid (ICS) treatment, a rate strikinglysimilar to that in the younger population.10,11 In older/elderly
patients, the impact of nonadherence to respiratory medications
includes increased rates of morbidity, health care expenditures,
hospitalizations, and possibly mortality, as well as unnecessary
escalation of therapy and reduced quality of life.12,13
Although there is a substantial body of evidence on patient-
level barriers and facilitators to medication adherence (see
Dima et al’s article, “Mapping the asthma care process: impli-
cations for research and practice,”14 in this issue), there is a need
for a single resource that synthesizes current understanding on
how a patient’s life stage may impact the patient’s adherence
behavior. Helping clinicians and researchers understand how age
may affect patients’ ability to perform the necessary steps
required to initiate and implement therapy, in order that they
may also persist with it, can help guide more informed adherence
decision making and targeted research. In this review, we discuss
the determinants of medication adherence that are of particular
consequence to children, adolescents, and the elderly, focusing
speciﬁcally on patients with asthma and COPD.
ADHERENCE TO ASTHMA MEDICATIONS IN
CHILDHOOD
Suboptimal adherence to asthma medications has been re-
ported at each step of the adherence pathway. Studies have
recorded noninitiation to inhaled therapy in 14% to 20% of
children15 and even higher rates (50%) of noninitiation for those
discharged from hospital after an exacerbation.11 Studies using
electronic monitoring devices to quantify therapy implementa-
tion in pediatric patients with asthma have also reported rates of
less than 50%.16 In the case of asthma—primarily managed by
inhaled therapy—observational studies have repeatedly reported
poor inhaler technique in children and poor proﬁciency of
inhaler administration by caregivers12,17-25 (for more informa-
tion, see Braido et al’s article, “‘Trying, but failing’ — the role of
inhaler technique and mode of delivery in respiratory medication
adherence,”26 in this issue). Even in the more closely monitored
interventional clinical trial setting, long-term persistence among
children to asthma medications has been shown to drop quite
dramatically over time, from around 78% at 3 months to 50%
by 2 years.27 Thus, children with asthma demonstrate subopti-
mal initiation and implementation of inhaled therapies, and poor
persistence over the longer term.
DETERMINANTS OF ADHERENCE TO ASTHMA
MEDICATION
School-aged children
“Then, the whining school-boy with his satchel
And shining morning face, creeping like snail
Unwillingly to school”28
The social environment for school-age children (5-15 years)
primarily consists of their family and peer networks at school,
both of which have been shown to affect medication adher-
ence.27,29,30 Caregiver attitudes derived from cultural and reli-
gious beliefs are strong determinants of medication adherence.31
If caregivers have concerns about the side effects of a medication
that outweigh their perception of its beneﬁt, they are less likely to
administer the medication.32,33 Beliefs about the efﬁcacy of the
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work may impact both the initiation and persistence phases of
adherence. A caregiver may administer medication for the min-
imal time believed necessary during an exacerbation, but not
persist as prescribed thereafter. In addition, depression among
caregivers has been shown to have a negative effect on medication
adherence among the children they care for and on their overall
levels of asthma control.34
With respect to peer networks and school environments,
children report concerns of stigmatization of their asthma when
they use an inhaler in public. Missing school activities and
inability to partake in sports can negatively affect children’s
emotional state and medication adherence, in particular their
adherence to ICS controller therapy.35 School policies or lack of
care coordination can result in children having limited access to
asthma medications during school hours.36 Increased monitoring
and direct observation of medication use by school nurses has
been shown to facilitate improved medication implementation.37
Young children are known to have greater difﬁculty using
inhaler devices correctly than do other older children. Spacers are
recommended to improve drug delivery and reduce common
inhaler technique errors in younger patients, but they are seldom
used in practice.38-41 Furthermore, spacer use, as well as inhalers,
can add to the stigma around asthma treatment in older children
and further reduce their motivation to implement and persist
with prescribed therapy.37 Ineffective inhaler use has important
clinical consequences because it can negatively affect both the
implementation and persistence phases of adherence (through
perceived lack of treatment beneﬁt by the child and/or the
caregiver) and lead to suboptimal treatment outcomes and
possible unnecessary escalation of therapy (eg, referral to severe
asthma services, or increased medication dose) by the clinician.
Adolescents
“Full of strange oaths, and bearded like the pard,
Jealous in honour, sudden, and quick in quarrel,
Seeking the bubble reputation”28
Adolescence is a developmental period that is marked by
increased interpersonal conﬂict as individuals seek to separate
from their parents and become more independent. It is not
surprising, therefore, that medication adherence is a particular
casualty during this stage of personal development as adolescents
seek to take on more responsibility for their medications without
parental monitoring and support. Research has demonstrated,
across chronic illness groups, that medication adherence and
clinic attendance decline signiﬁcantly during adolescence.42
There is a known paradox during adolescence with regard to
medication adherence. During this time, the patients’ knowledge
and understanding about their disease and related medications
improves, while their adherence to medication declines. One
explanation is that adolescence is characterized by changes in
reasoning and hypothetical thinking, which, in turn, can affect
how information on medications and illness is received (and
needs to be communicated) to help optimize adherence to
therapy.43 Unless the adolescent has been engaged and involved
in the decision to use a medication, and his or her concerns have
been addressed, initiation, implementation, and persistence will
be at risk.As adolescents begin to take on more responsibility for their
medications, and as they establish autonomy and independence
from their parents, they may become less motivated to take
medications or may be more likely to forget them than when
supervised by a caregiver. As parents begin to withdraw their
support and supervision, persistence may fall.42 Frequently, this
change in responsibility occurs without direct communication
between adolescents and parents, which can lead to mis-
assumptions about who is responsible, increased parent/child
conﬂict, and subsequent lower adherence. In adolescence, other
psychosocial inﬂuences, such as psychological distress, depres-
sion, family conﬂict, and substance abuse, correlate with poor
adherence to medications.44
THE ROLE OF HEALTH CARE IN FACILITATING
ADHERENCE IN CHILDREN AND ADOLESCENTS
The organization of the health care system can inﬂuence
medication adherence in school-aged children with asthma, with
one obvious facilitator being good access to health care coverage.
In the United States, for example, children have access to health
insurance through Medicaid or state programs, which provide
their medications free of charge, or for a nominal fee. Coverage
also extends to preventive health care administered through a
primary care physician. These features of childhood insurance
plans permit continuity of care and offer an opportunity to
optimize adherence to therapy in children. For these services to
be most effective, it is important that providers use established
asthma care guidelines, which recommend the use of objective
asthma control questionnaires and ongoing inhaler instruction to
improve adherence (all steps) and overall asthma control.45
PRACTICAL ADHERENCE INTERVENTIONS IN
CHILDHOOD ASTHMA
Adolescents represent a potentially rich resource for adherence
research—their engagement in participatory research can help
identify and inform developmentally relevant interventions.46
The increasing technological sophistication of young adults,
often exceeding that of clinicians and clinical investigators, sug-
gests that technology-based solutions could offer a promising
opportunity for targeting adherence interventions. Substantive
improvements in important asthma outcomes in children, such
as increased school attendance, were reported in association with
the introduction of electronic reminders to prompt preventer
therapy use.47 This type of intervention may help children to
improve the implementation aspect of their medication adher-
ence, particularly if accompanied by an inhaler technique
assessment. Further work is required to understand how best to
implement and sustain technology-based adherence interventions
in the longer term and in larger populations.
Given the important role that peers play in adherence with
childhood asthma therapies, many studies have investigated the
potential for peer support to enhance adherence43,48,49; some
such studies have demonstrated beneﬁts in terms of improved
asthma-related outcomes.50,51
The school environment represents another opportunity to
support improved adherence. Schools are places of learning
where new skills are taught and developed and, as such, may have
a role to play in supporting the delivery of asthma self-
management interventions.52 Previous research has shown that
multilevel interventions that work with both schools and families
FIGURE 1. Medication hording, a consequence of poor adherence.
An example of the consequences that arise from poor health lit-
eracy and poor patient and physician communication. This
photograph was taken in a patient’s home by a health care worker
visiting a patient with COPD. The patient who had government-
funded medications was confused by changing prescriptions be-
tween primary and secondary care. He reported being unable to
discuss his concerns with either provider and hence simply did not
take his medications (photo courtesy of Ms Brenda Deering).
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a majority of their day at school, it is imperative that school staff
are well trained and prepared to manage asthma symptoms that
may arise. Appropriate staff training and access to medications
may prevent asthma worsening and poor outcomes.
Asthma is the second most common reason for health care
utilization in young adults in America, beaten only by trauma-
related events.31 Mortality rates among adolescents and young
adults (ages 16-21 years) with asthma are 7 times higher than
among younger children with asthma. These higher mortality
rates may be the result of less frequent use of primary or pre-
ventative health care among adolescents and young adults, and/
or lower rates of prescription reﬁlls and higher use of emergency
departments as a substitute for primary care asthma management
(particularly among minority groups).
Research in other chronic illness populations has shown that
guideline-speciﬁc health care transition services (from pediatric to
adult care) are associated with reduced medical complications,
improved patient-reported outcomes, greater adherence to care,
improved continuity of care, positive patient experience, and
lower cost.54 However, despite the positive effect of transition
practices on outcomes, there has been limited focus on the health
care transition from pediatric to adult care in asthma.55
ADHERENCE TO RESPIRATORY MEDICATIONS IN
OLDER PATIENTS
“His youthful hose, well saved, a world too wide
For his shrunk shank, and his big manly voice,
Turning again toward childish treble, pipes
And whistles in his sound.”28
Determinants of respiratory medication adherence in
older patients
At present there is little research investigating the speciﬁc
patient barriers and facilitators to adherence in seniors with
asthma and COPD, representing a signiﬁcant and important gap
in the literature. Studies have shown that older people tend to
have strong medication views, including distrust of potential side
effects, concerns over reduced effectiveness over time (resulting
in a desire to postpone taking medications until they are
required), concerns over addiction and medication dependency,
and a dislike of the burden associated with taking large numbers
of medications.56-63
A number of features distinguish elderly patients from their
younger counterparts and can impact their decision to adhere to
asthma and COPD treatments. Advanced age often brings
multiple comorbidities, multiple medications, and, for many,
cognitive deﬁcits, which make medication adherence particularly
problematic.64-67 Where cognitive impairment is present, pa-
tients may be confused as to why, how, and when to use different
treatments. Indeed they may simply forget to take treatments.
Moreover, poor motivation and apathy with respect to disease
management is common in the elderly perhaps due to fatalism or
accepting decline in functionality as part of the normal aging
process.
Loss of a partner and poorer mobility may reduce social
support, increase isolation, and reduce access to health careservices, all of which can impact the patient’s ability to initiate,
implement, and persist with prescribed treatments. For a pro-
portion of patients, diagnostic confusion can be an important
barrier to adherence. A history of childhood asthma and adult
smoking may result in mixed disease in old age68 (partially
reversible or ﬁxed airﬂow obstruction and evidence of atopy) and
a history of apparently contradictive diagnoses that leave the
patient unsure as to the appropriateness of prescribed treat-
ment69 and disinclined, or less able, to self-manage their dis-
ease.70 Furthermore, there are important age-related changes to
the structure and function of the respiratory system and a poorer
response to treatment that can negatively affect clinical outcomes
and conﬁdence in therapy in elderly patients with respiratory
problems. These changes contribute to more frequent exacer-
bations and higher mortality rates in older populations with
asthma and COPD and are likely to inﬂuence medication
adherence negatively as a result of poor perceived treatment
effectiveness.71 This is compounded by a poorer perception and/
or habituation to asthma symptoms in older patients with res-
piratory problems, especially those with long-standing disease.72
One facilitator of adherence in the elderly (as in children) is
the availability of reduced cost or free medication, but subopti-
mal implementation and poor persistence in elderly populations
appears to manifest itself by accumulation of unused medication
or “hording.” An example of medication hording is shown in
Figure 1. Hording of medications underscores that pharmacy
reﬁll records may not accurately identify poor adherence.
ROLE OF PATIENTS-HEALTH CARE
PROFESSIONAL INTERACTIONS IN FACILITATING
ADHERENCE IN THE ELDERLY
Although health care for patients older than 65 years is pro-
vided at no or low cost in many countries, such provision does
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provider.73 It is plausible that this poor continuity of care may
negatively affect respiratory medication adherence. For example,
in one study, patients with a single medication prescriber had
30% higher medication persistence than did those with 4 or
more prescribers.74 Older patients may beneﬁt from access to
one health care professional that they trust and who can repeat
and reinforce consistent care recommendations to improve
motivation and adherence.75
Clinicians must be sure to appropriately treat airway inﬂam-
mation in seniors with asthma and COPD who may be at great
risk for lung function decline with undertreatment due to their
advanced age. It appears that clinicians may avoid prescribing
certain treatments because of diagnostic uncertainty or concerns
about safety in seniors, particularly where clinical drug trials have
not included elderly populations. Indeed, a Canadian study in
those older than 65 years with asthma showed that prescribing of
ICS was as low as 40% after an acute exacerbation and lower still
in those 80 years or older.76
The communication style used by health care professionals
(eg, use of technical terms or differences in cultural backgrounds
between patients and health care workers) can also affect in-
teractions and medication adherence in older patients.77
Furthermore, failing to appreciate the attitudes and health be-
liefs of older patients can make patients feel that their concerns
are not being recognized or addressed. Shared decision making is
often underused in therapeutic decision making with seniors, but
it can play an important role in patient engagement if it is
appropriately tailored to account for possible lower health literacy
and/or coexisting cognitive impairment.
ROLE OF THE FAMILY UNIT AND SOCIAL CARE
Evidence suggests a signiﬁcant relationship between adherence
and family cohesion and/or social support. In a meta-analysis of
studies that included those in elderly populations, adherence was
1.7-fold higher in cohesive families and 1.5-fold lower in patients
from families in conﬂict.78 Marital status and living with another
person was also shown to improve adherence modestly. Social
support is thought to positively affect adherence behaviors by
providing both practical and emotional support (facilitating
optimism, self-esteem and protecting the patients from the
stresses of being ill while reducing depression, and improving sick
role behavior). Such factors may be particularly relevant in the
elderly who, through comorbidity, loss, and poorer mobility,
may have fewer or more restricted social networks.78 Depression
and consequently poor motivation are a particular factor that
links these life events with poor adherence.79
INDIVIDUAL CONSIDERATIONS IN OLDER
PATIENTS WITH SUBOPTIMAL RESPIRATORY
MEDICATION ADHERENCE
As in younger people, correct inhaler technique has an
important role in determining adherence to inhaled therapies
prescribed in the elderly (for more information, see Braido et al’s
article, “‘Trying, but failing’ — the role of inhaler technique and
mode of delivery in respiratory medication adherence,”26 in this
issue).80-84 Speciﬁc inhaler handling errors and poor technique in
the elderly can diminish the effective delivery and beneﬁt of
treatment and reduce patient’s perception of treatment effec-
tiveness and motivation to persist. Elderly patients with advancedCOPD, for example, often have considerable lung hyperinﬂation
and limited ability to generate sufﬁcient inhalational airﬂow to
achieve adequate drug delivery if prescribed a dry powder inhaler.
Mild cognitive impairment in patients with COPD (prevalence
up to 50% in some studies) or asthma can lead to failures in
forward planning and to difﬁculty in implementing learned
tasks.85,86 These individuals may quickly forget both how and
when to use their inhaler,87 and may more readily remember
what they have been told not to do rather than what they should
do. Factoring such considerations into education for seniors and
tailoring training styles to accommodate cognitive impairment is
therefore important.PRACTICAL ADHERENCE INTERVENTIONS IN
OLDER ADULTS
Every step of the adherence pathway is a dynamic process
beneﬁting from regular medication reviews. Nonadherence is a
signiﬁcant determinant of poor control; linking and triangulation
of prescribing records (and prescribing and pharmacy dispensing
records) can help to identify suboptimal adherence and provide an
opportunity to engage the patient and to positively affect
adherence.88
Clinicians can help to improve adherence in their patients by
understanding patients’ individual treatment aspirations and
tailoring management and management expectations accord-
ingly. Indeed, 2 randomized controlled studies conducted in
seniors with asthma compared patient-centered, tailored asthma
education (active group) with standard written information or
usual care (control) and found that tailoring education improved
asthma control and other outcomes such as quality of life or self-
care conﬁdence.72,89 One of the studies measured adherence and
showed a trend toward, but not statistically signiﬁcantly, better
adherence in the intervention versus control group.
The use of appropriate communication skills for adherence is
critical.90 It is important to ensure the patient does not feel
threatened by the clinician. It is better to frame the conversation in
such a way that rather than expecting full adherence, suboptimal
adherence is regarded as “normal” and that the clinician targets
information at the health literacy level of the patient—Assessment
of medication adherence should be incorporated into structured
clinical reviews such as the holistic SIMPLES (Smoking status,
Inhaler technique, Monitoring, Pharmacotherapy Lifestyle, (pa-
tient) Education, Support) assessment approach,91 and potentially
integrated into future technology-based solutions to suboptimal
adherence to asthma and COPD medications.92
From a community pharmacy perspective, pharmacists can
play an important role in optimizing respiratory medication
adherence, particularly by reviewing and teaching inhaler tech-
nique when patients reﬁll their prescriptions. The pharmacist’s
role in shared decision-making approaches, however, may need
to be adapted for elderly patients because seniors may prefer to
depend solely on their physician’s advice. However, as the
penetration of smartphone devices into the older population
increases, the opportunities for interventions that use these
technologies, as in younger patients, will increase.
Although more research is needed into the most effective ap-
proaches for optimizing medication adherence in seniors with
asthma and COPD, Table I summarizes a number of practical op-
portunities (recommended by the authors of this review) for health
care practitioners to intervene to support medication adherence.
TABLE I. Future adherence research needs in relation to
age-related determinants of respiratory medication adherence
Childhood and adolescence
 “Getting the narrative right”: Assessment of effective
communication styles (and health care professional training in
them) for supporting adherence
 Understanding how to develop and tailor effective adherence
interventions that actively engage children (and carer(s) of younger
children)
 Development of a “behavioral taxonomy” to characterize the role
of the parent in optmizing adherence
Adolescence
 Assessment of transition-to-adult-care approaches, their effect on
medication adherence, and opportunities for improvement
 Evaluation of effective adherence support mechanisms for
adolescents (online, friends, teachers, general practitioners)
Elderly patients
 Investigate the speciﬁc attitudes toward medication use and the
adherence behaviors of seniors with asthma and COPD
 Development of interventions that tackle the adherence barriers
speciﬁc to older patients (eg, cognition, polypharmacy,
and immobility)
 Identiﬁcation of methods for ongoing inhaler technique support
outside the professional health care environment
 Evaluation of the role of multiple inhaler types prescribing on
medication adherence
 Evaluation of the role of electronic monitors and reminders
for missed doses in elderly patients with COPD
 Evaluation of the role of secondary care experiences on
medication adherence (ie, direct-to-ward vs to ward via the
emergency room)
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UNDERSTANDING OF AGE-RELATED
DETERMINANTS OF RESPIRATORY MEDICATION
ADHERENCE
There are many outstanding needs to improve the research
understanding and clinical implications and opportunities of
medication adherence in asthma and COPD, at both ends of the
age spectrum (see Table I). Most studies outlined above suggest
that determinants of medication adherence are likely to differ
between age groups and vary between the different steps of the
adherence pathway (initiation, implementation, persistence), but
well-designed studies are required to conﬁrm and further explore
these assertions. There is a particular need for research into the
determinants of adherence in elderly patients with respiratory
disease and to identify effective adherence interventions in this
age group. In adolescents with asthma, there may be signiﬁcant
gaps in access to effective adherence support given the cognitive
and developmental changes of this age group as well as the
disruptive transition into adult care, and more research is needed
to quantify and qualify the additional risk faced by this age group
and to mitigate accordingly.
Across all age groups, research is required to identify the
barriers and facilitators speciﬁc to initiation, implementation,
and persistence adherence. The emergence of ever more sophis-
ticated and reliable measurement tools (eg, electronic monitoring
devices and linked electronic medical records) may help in this
end.A key requirement for successful implementation of adherence
interventions in everyday clinical practice is demonstration of both
clinical effectiveness and cost-effectiveness; future studies should
be designed to answer both questions and avoid unnecessary bar-
riers to uptake. The most valuable interventions are likely to be
those that are “scalable,” that is, complex enough to be effective,
but also simple enough for feasible delivery in routine clinical
settings. Expensive, complicated, multifaceted interventions that
use specialized research teams should be carefully reviewed for
ultimate feasibility before work is undertaken.
CONCLUSIONS
This review highlights how nuanced the relationship between
patient age and medication adherence can be and the myriad of
different age-related considerations that should be taken into
account to tailor management style and treatment choice to
patients’ stage of physical and cognitive development (or
decline). Strategies to promote adherence to medications should
start by assessing age-related barriers to initiation, implementa-
tion, and persistence and tailoring treatment choice (eg, inhaler
device) and consultation style to the health literacy level of the
patient. Methods need to be reﬁned for the ongoing monitoring
of adherence, as well as for the effective targeting of in-
terventions, at each adherence step and developmental stage
(which will be dynamic over the course of a chronic respiratory
condition) in each individual patient.
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